Susquehanna International Group, LLP Citius Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 165,063 shares of CTXR stock, worth $33,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165,063
Previous 640,539
74.23%
Holding current value
$33,012
Previous $371,000
77.9%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CTXR
# of Institutions
59Shares Held
23.4MCall Options Held
83.1KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY7.28MShares$1.46 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$1.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$375,7900.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$361,1450.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$231,7010.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $29.2M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...